How to Buy Nath Bio-Genes (I) Ltd Shares?
You can easily buy the stocks/shares of Nath Bio-Genes (I) Ltd (NATHBIOGEN) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Nath Bio-Genes (I) Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of NATHBIOGEN as on 15th May 2025 is ₹175.92What is the return on Nath Bio-Genes (I) Ltd share?
The past returns of Nath Bio-Genes (I) Ltd (NATHBIOGEN) share are- Past 1 week: N/A
- Past 1 month: N/A
- Past 3 months: 40.82
- Past 6 months: 12.04
- Past 1 year: -5.11
- Past 3 years: 29.80
- Past 5 years: -37.61
What is the Dividend yield % on Nath Bio-Genes (I) Ltd share?
The current dividend yield of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is 0.95What is the Market Cap of Nath Bio-Genes (I) Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is ₹400.59Cr as of 15th May 2025What is the 52 Week High and Low of Nath Bio-Genes (I) Ltd?
The 52-week high and low of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is ₹264.31 and ₹137.55.What is the PE and PB ratio of Nath Bio-Genes (I) Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Nath Bio-Genes (I) Ltd are 10.38 and 0.66 respectively.Which sector does Nath Bio-Genes (I) Ltd belong to?
Nath Bio-Genes (I) Ltd (NATHBIOGEN) belongs to the Consumer Staples sector & Agro Products sub-sector.What are the peers or stocks similar to Nath Bio-Genes (I) Ltd?
The peers or stocks similar to Nath Bio-Genes (I) Ltd are: and many others.Can't decide whether or not to buy Nath Bio-Genes (I) Ltd?
Worry no more! Login to Tickertape and check out Nath Bio-Genes (I) Ltd (NATHBIOGEN) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Nath Bio-Genes (I) Ltd?
The 52-week high and low of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is ₹264.31 and ₹137.55.1. Test Stocks FAQ for Nath Bio-Genes (I) Ltd Shares?
You can easily buy the stocks/shares of Nath Bio-Genes (I) Ltd (NATHBIOGEN) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Nath Bio-Genes (I) Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of NATHBIOGEN as on 15th May 2025 is ₹175.92
Nath Bio-Genes (I) Ltd
NATHBIOGEN Share Price
175.920.65% (+1.14)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
NATHBIOGEN Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NATHBIOGEN Performance & Key Metrics
NATHBIOGEN Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 10.38 | 0.66 | 0.95% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.43 | 9.28 | 1.71% |
NATHBIOGEN Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
NATHBIOGEN Company Profile
Nath Bio-Genes (India) is engaged in hybrid seed business and production, processing and marketing of hybrid and genetically modified (GM) seeds
GODREJAGRO
PE Ratio
34.25
34.25
1Y Return
13.81%
13.81%
Buy Reco %
80.00
80.00
PE Ratio
21.08
21.08
1Y Return
17.62%
17.62%
Buy Reco %
100.00
100.00
PE Ratio
28.98
28.98
1Y Return
34.23%
34.23%
Buy Reco %
—
—
GRMOVER
PE Ratio
36.42
36.42
1Y Return
97.24%
97.24%
Buy Reco %
—
—
BNHOLDINGS
PE Ratio
110.64
110.64
1Y Return
53.11%
53.11%
Buy Reco %
—
—
NATHBIOGEN Sentiment Analysis
NATHBIOGEN Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
NATHBIOGEN Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
NATHBIOGEN Stock Growth Drivers
NATHBIOGEN Stock Growth Drivers
2Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
NATHBIOGEN Stock Challenges
NATHBIOGEN Stock Challenges
3Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
NATHBIOGEN Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
NATHBIOGEN Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
NATHBIOGEN
NATHBIOGEN
Income
Balance Sheet
Cash Flow
Annual Normal View
NATHBIOGEN Income Statement
NATHBIOGEN Income Statement
Annual Normal View
| Financial Year | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 280.21 | 301.91 | 336.70 | 369.99 | 370.00 | |||||
Raw Materials | 3.56 | 5.31 | 12.26 | 315.11 | 315.11 | |||||
| Power & Fuel Cost | 1.07 | 1.39 | 1.13 | |||||||
| Employee Cost | 24.78 | 23.32 | 27.58 | |||||||
| Selling & Administrative Expenses | 89.99 | 112.25 | 139.47 | |||||||
| Operating & Other expenses | 210.53 | 110.26 | 102.23 | |||||||
EBITDA | -49.72 | 49.38 | 54.03 | 54.88 | 54.89 | |||||
| Depreciation/Amortization | 3.08 | 3.01 | 3.26 | 3.82 | 3.83 | |||||
| PBIT | -52.80 | 46.37 | 50.77 | 51.06 | 51.06 | |||||
| Interest & Other Items | 10.64 | 10.21 | 9.20 | 10.48 | 10.49 | |||||
| PBT | -63.44 | 36.16 | 41.57 | 40.58 | 40.57 | |||||
| Taxes & Other Items | 3.95 | 1.13 | 1.95 | 1.98 | 1.99 | |||||
| Net Income | -67.39 | 35.03 | 39.62 | 38.60 | 38.58 | |||||
| EPS | -35.46 | 18.43 | 20.85 | 20.14 | 20.30 | |||||
| DPS | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | |||||
| Payout ratio | — | 0.11 | 0.10 | 0.10 | 0.10 |
NATHBIOGEN Company Updates
NATHBIOGEN Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
NATHBIOGEN Past Performance & Peer Comparison
NATHBIOGEN Past Performance & Peer Comparison
Comparing 3 stocks from
Consumer StaplesAgro Products
Compare valuation-basic on Screener
Consumer StaplesAgro Products
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Nath Bio-Genes (I) Ltd | 10.38 | 0.66 | 0.95% |
| Godrej Agrovet Ltd | 34.25 | 5.04 | 1.44% |
| Gujarat Ambuja Exports Ltd | 21.08 | 1.89 | 0.22% |
| Jubilant Agri and Consumer Products Ltd | 28.98 | 11.05 | — |
NATHBIOGEN Stock Price Comparison
Compare NATHBIOGEN with any stock or ETFCompare NATHBIOGEN with any stock or ETF
NATHBIOGEN
NATHBIOGEN Holdings
NATHBIOGEN Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
NATHBIOGEN Promoter Holdings Trend
NATHBIOGEN Promoter Holdings Trend
NATHBIOGEN Institutional Holdings Trend
NATHBIOGEN Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
NATHBIOGEN Shareholding Pattern
NATHBIOGEN Shareholding Pattern
NATHBIOGEN Shareholding History
NATHBIOGEN Shareholding History
Foreign Institutions
Mutual Funds Invested in NATHBIOGEN
Mutual Funds Invested in NATHBIOGEN
No mutual funds holding trends are available
Top 1 Mutual Funds holding Nath Bio-Genes (I) Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.8058% | Percentage of the fund’s portfolio invested in the stock 0.25% | Change in the portfolio weight of the stock over the last 3 months 0.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 72/79 (-59) |
Compare 3-month MF holding change on Screener
smallcases containing NATHBIOGEN stock
smallcases containing NATHBIOGEN stock
Looks like this stock is not in any smallcase yet.
NATHBIOGEN Events
NATHBIOGEN Events
NATHBIOGEN Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
NATHBIOGEN Dividend Trend
No dividend trend available
NATHBIOGEN Upcoming Dividends
NATHBIOGEN Upcoming Dividends
No upcoming dividends are available
NATHBIOGEN Past Dividends
NATHBIOGEN Past Dividends
Cash Dividend
Ex DateEx DateAug 9, 2024
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Aug 9, 2024
Cash Dividend
Ex DateEx DateJul 4, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Jul 4, 2023
Cash Dividend
Ex DateEx DateJun 23, 2022
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Jun 23, 2022
Cash Dividend
Ex DateEx DateAug 18, 2021
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Aug 18, 2021
NATHBIOGEN Stock News & Opinions
NATHBIOGEN Stock News & Opinions
Articles & Videos
Corporate
Nath Bio-Genes (India) to convene AGM
Nath Bio-Genes (India) announced that the 32th Annual General Meeting(AGM) of the company will be held on 22 August 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Nath Bio-Genes (India) recommends final dividend
Nath Bio-Genes (India) announced that the Board of Directors of the Company at its meeting held on 29 April 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 43.51% in the March 2025 quarter
Net profit of Nath Bio-Genes (India) declined 43.51% to Rs 1.48 crore in the quarter ended March 2025 as against Rs 2.62 crore during the previous quarter ended March 2024. Sales rose 20.75% to Rs 51.97 crore in the quarter ended March 2025 as against Rs 43.04 crore during the previous quarter ended March 2024. For the full year,net profit declined 2.57% to Rs 38.60 crore in the year ended March 2025 as against Rs 39.62 crore during the previous year ended March 2024. Sales rose 9.71% to Rs 364.91 crore in the year ended March 2025 as against Rs 332.62 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales51.9743.04 21 364.91332.62 10 OPM %0.819.13 -13.6414.99 - PBDT2.913.27 -11 43.8641.38 6 PBT1.572.28 -31 40.0438.11 5 NP1.482.62 -44 38.6039.62 -3 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Nath Bio-Genes (India) to table results
Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 29 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 30.81% in the December 2024 quarter
Net profit of Nath Bio-Genes (India) declined 30.81% to Rs 2.65 crore in the quarter ended December 2024 as against Rs 3.83 crore during the previous quarter ended December 2023. Sales rose 16.16% to Rs 36.87 crore in the quarter ended December 2024 as against Rs 31.74 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales36.8731.74 16 OPM %21.7817.77 - PBDT4.622.85 62 PBT3.792.09 81 NP2.653.83 -31 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Nath Bio-Genes (India) to convene board meeting
Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 26.49% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) declined 26.49% to Rs 1.11 crore in the quarter ended September 2024 as against Rs 1.51 crore during the previous quarter ended September 2023. Sales rose 42.62% to Rs 32.19 crore in the quarter ended September 2024 as against Rs 22.57 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.1922.57 43 OPM %14.9422.06 - PBDT1.912.61 -27 PBT1.091.85 -41 NP1.111.51 -26 Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Nath Bio-Genes (India) standalone net profit rises 79.50% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) rose 79.50% to Rs 2.89 crore in the quarter ended September 2024 as against Rs 1.61 crore during the previous quarter ended September 2023. Sales rose 42.62% to Rs 32.19 crore in the quarter ended September 2024 as against Rs 22.57 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.1922.57 43 OPM %20.3822.60 - PBDT3.692.72 36 PBT2.861.96 46 NP2.891.61 80 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Nath Bio-Genes (India) announces board meeting date
Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 0.24% in the June 2024 quarter
Net profit of Nath Bio-Genes (India) declined 0.24% to Rs 33.35 crore in the quarter ended June 2024 as against Rs 33.43 crore during the previous quarter ended June 2023. Sales rose 3.66% to Rs 243.88 crore in the quarter ended June 2024 as against Rs 235.28 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales243.88235.28 4 OPM %14.9815.74 - PBDT34.4334.38 0 PBT33.6033.62 0 NP33.3533.43 0 Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant